A 45-year-old man with HIV and hepatitis C virus (HCV) genotype 2 infection has a clinic visit to discuss starting HCV treatment. He has not previously received HCV therapy. He has fully suppressed HIV RNA levels on antiretroviral therapy and has a CD4 count of 468 cells/mm3. He has compensated cirrhosis.
Which one of the following pangenotypic direct-acting antiviral regimens is considered a recommended HCV simplified treatment option in people with HIV?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 29th, 2023
September 29th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5